SlideShare a Scribd company logo
W
QUALITY CONTROL
Human ready-to-use stable liquid multi-analyte control for specific
proteins including antibody isotypes and complement components
Spon-Smith C., Shanks A., Rodríguez M.L., Campbell J., FitzGerald S.P | Randox Laboratories Ltd - Diamond Road, Crumlin, County Antrim, N. Ireland, BT29 4QY, United Kingdom.
Introduction
The performance and interpretation of tests for the diagnosis and management of a variety
of immune-mediated diseases requires the maintenance of high-quality output. Quality
control material is required to monitor the accuracy and precision of the tests,this will lead
to improved result quality.
The use of liquid stable multi-analyte control material consolidates the test menu, reduces
the risk of errors associated with reconstitution and decreases the operator training
requirements. A human liquid ready-to-use,stable multi-analyte control containing antibody
isotypes, complement components and other specific proteins is reported.
Methodology
•Three levels of human liquid control material containing 27 analytes were prepared.
• Open vial stability was determined as the percentage recovery of each level of analyte
opened and stored at +2°C to +8°C over a period of 30 days related to day 0 at
+2°C to +8°C.
• Shelf life was assessed as the percentage recovery of each level of analyte stored at
+2°C to +8°C compared to the same material stored at -70°C over a 48 month period.
Measurements were made on various automated systems.
Conclusion
Thehumanliquidmulti-analytecontrolmaterialforspecificproteinscontained27parameters
at three levels covering clinically relevant ranges.This control material presented an open
vial stability of 30 days and data supporting at least a 2 year shelf life.This control is of value
as a convenient, ready-to-use material for clinical applications.
Randox Laboratories Ltd, 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom
+44 (0) 28 9442 2413 +44 (0) 28 9445 2912 marketing@randox.com randoxqc.comQUALITY CONTROL
Analyte Unit
Level 1 Level 2 Level 3
Method
Target Range Target Range Target Range
CRP
mg/L 27.5 22.0-33.0 54.6 43.7-65.5 81.8 65.4-98.2 Turbidimetric
mg/L 25.3 20.2-30.4 52.9 42.3-63.5 79.1 63.3-94.9 Nephelometric
mg/L 36.2 29.0-43.4 58.6 47-70.3 64.5 51.6-77.4 Vitros
Complement
C3
g/L 0.72 0.57-0.86 1.45 1.16-1.74 2.17 1.74-2.60
Turbidimetric
mg/dL 72.0 57.6-86.4 145 116-174 217 174-260
g/L 0.727 0.58-0.87 1.49 1.19-1.79 2.27 1.82-2.72
Nephelometric
mg/dL 72.7 58.2-87.2 149 119-179 227 182-272
g/L 0.714 0.57-0.85 1.40 1.12-1.68 2.15 1.72-2.58
Vitros
mg/dL 71.4 57.1-85.7 140 112-168 215 172-258
Complement
C4
g/L 0.175 0.14-0.21 0.35 0.28-0.42 0.53 0.42-0.63
Turbidimetric
mg/dL 17.5 14.0-21.0 35 28-42 53 42.4-63.6
g/L 0.196 0.15-0.23 0.399 0.31-0.47 0.60 0.48-0.72
Nephelometric
mg/dL 19.6 15.7-23.5 39.9 31.9-47.9 60.4 48.3-72.5
g/L 0.181 0.14-0.22 0.356 0.28-0.42 0.53 0.42-0.63
Vitros
mg/dL 18.1 14.5-21.7 35.6 28.5-42.7 53 42.4-63.6
Free Kappa
Light Chains
mg/L 17.9 14.3-21.5 29.9 23.9-35.9 34 25.5-42.5 Turbidimetric
mg/L 21.7 17.4-26.0 34.2 27.4-41.0 40.2 30.2-50.3 Nephelometric
Free Lambda
Light Chains
mg/L 16.9 13.5-20.3 29.4 23.5-35.3 40.3 30.2-50.4 Turbidimetric
mg/L 18.4 14.7-22.1 33.3 26.6-40 46.3 34.7-57.9 Nephelometric
IgA
g/L 1.22 0.91-1.53 2.42 1.82-3.03 3.65 2.74-4.56
Turbidimetric
mg/dL 122 91.5-153 242 182-302 365 274-456
g/L 1.29 0.96-1.61 2.64 1.98-3.30 4.04 3.03-5.05
Nephelometric
mg/dL 129 96.8-161 264 198-330 404 303-505
g/L 1.18 0.88-1.48 2.48 1.86-3.10 3.46 2.60-4.33
Vitros
mg/dL 118 88.5-148 248 186-310 346 260-432
IgE
KIU/L
=
IU/mL
89.3 71.4-107 175 140-210 262 210-314 Turbidimetric
KIU/L
=
IU/mL
100 80-120 198 158-238 310 248-372 Nephelometric
KIU/L
=
IU/mL
103 82.4-124 200 160-240 299 239-359 Chemiluminescence
KIU/L
=
IU/mL
100 80-120 211 169-253 299 239-359
Enzyme
Immunoassay
KIU/L
=
IU/mL
105 84-126 210 168-252 315 252-378 Fluorimetric
IgG
g/L 7.0 5.74-8.26 14 11.5-16.5 21 17.2-24.8
Turbidimetric
mg/dL 700 574-826 1400 1150-1650 2100 1720-2480
g/L 7.34 6.02-8.66 14.5 11.9-17.1 21.6 17.7-25.5
Nephelometric
mg/dL 734 602-866 1450 1190-1710 2160 1770-2550
g/L 7.14 5.85-8.43 14 11.5-16.5 19.6 16.1-23.1
Vitros
mg/dL 714 585-843 1400 1150-1650 1960 1610-2310
IgM
g/L 0.94 0.75-1.13 1.87 1.50-2.24 2.83 2.26-3.40
Turbidimetric
mg/dL 94 75.2-113 187 150-224 283 226-340
g/L 0.99 0.79-1.19 1.96 1.57-2.35 2.95 2.36-3.54
Nephelometric
mg/dL 99 79.2-119 196 157-235 295 236-354
g/L 0.917 0.73-1.10 1.97 1.58-2.36 2.73 2.18-3.28
Vitros
mg/dL 91.7 73.4-110 197 158-236 273 218-328
Kappa Light
Chain
g/L 1.83 1.46-2.20 3.71 2.97-4.45 5.55 4.16-6.94
Turbidimetric
mg/dL 183 146-220 371 297-445 555 416-694
g/L 1.87 1.50-2.24 3.57 2.86-4.28 5.40 4.05-6.75
Nephelometric
mg/dL 187 150-224 357 286-428 540 405-675
Lambda Light
Chain
g/L 0.924 0.73-1.11 1.87 1.50-2.24 2.89 2.17-3.61
Turbidimetric
mg/dL 92.4 73.9-111 187 150-224 289 217-361
g/L 0.962 0.77-1.15 1.88 1.50-2.26 2.87 2.15-3.59
Nephelometric
mg/dL 96.2 77-115 188 150-226 287 215-359
Results - Examples of typical ranges
Open vial stability
Temperature Time period
Recovery (%) for different
concentration levels for all
the analytes
+2ºC to +8ºC 30 days (from day 0) 90-110
Shelf life stability
Temperature Time period
Recovery (%) for different
concentration levels for all
the analytes
+2ºC to +8ºC 48 months 90-110
Stability
AFP Complement C3 Kappa Light Chain (free)
Albumin Complement C4 Lambda Light Chain
α-I-Antitrypsin CRP Lambda Light Chain (free)
α-I-Acid Glycoprotein Haptoglobin Prealbumin (Transthyretin)
α-2-Macroglobulin IgA Serum Ferritin
ASO IgE RF
Anti-thrombin III IgG RBP
β-2-Microglobulin IgM Total Protein
Ceruloplasmin Kappa Light Chain Transferrin
Analytes

More Related Content

What's hot

Consolidate & Save
Consolidate & SaveConsolidate & Save
Consolidate & Save
Randox
 
Using QC Multi-rules
Using QC Multi-rulesUsing QC Multi-rules
Using QC Multi-rules
Randox
 
How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?
Randox
 
Guide to running QC
Guide to running QCGuide to running QC
Guide to running QC
Randox
 
Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674
Randox
 
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Randox
 
How to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational GuideHow to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational Guide
Randox
 
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Randox
 
How to Measure Uncertainty
How to Measure UncertaintyHow to Measure Uncertainty
How to Measure Uncertainty
Randox
 
Acusera Third Party Controls
Acusera Third Party ControlsAcusera Third Party Controls
Acusera Third Party Controls
Randox
 
EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649
Randox
 
Acusera Third Party Quality Controls for Medical Laboratories
Acusera Third Party Quality Controls for Medical Laboratories Acusera Third Party Quality Controls for Medical Laboratories
Acusera Third Party Quality Controls for Medical Laboratories
Randox
 
The Importance of Third Party Controls
The Importance of Third Party ControlsThe Importance of Third Party Controls
The Importance of Third Party Controls
Randox
 
Acusera 24.7 QC Data Management
Acusera 24.7 QC Data ManagementAcusera 24.7 QC Data Management
Acusera 24.7 QC Data Management
Randox
 
Understanding statistics in laboratory quality control
Understanding statistics in laboratory quality controlUnderstanding statistics in laboratory quality control
Understanding statistics in laboratory quality control
Randox
 
Monitoring EQA / PT Performance
Monitoring EQA / PT PerformanceMonitoring EQA / PT Performance
Monitoring EQA / PT Performance
Randox
 
LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17
Randox
 
Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory
Randox
 
Acusera 24.7 Interlaboratory Data Management
Acusera 24.7 Interlaboratory Data Management Acusera 24.7 Interlaboratory Data Management
Acusera 24.7 Interlaboratory Data Management
Randox
 
WESTGARD RULES
WESTGARD RULESWESTGARD RULES

What's hot (20)

Consolidate & Save
Consolidate & SaveConsolidate & Save
Consolidate & Save
 
Using QC Multi-rules
Using QC Multi-rulesUsing QC Multi-rules
Using QC Multi-rules
 
How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?How often is Right for Laboratory Quality Control?
How often is Right for Laboratory Quality Control?
 
Guide to running QC
Guide to running QCGuide to running QC
Guide to running QC
 
Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674
 
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
 
How to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational GuideHow to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational Guide
 
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
 
How to Measure Uncertainty
How to Measure UncertaintyHow to Measure Uncertainty
How to Measure Uncertainty
 
Acusera Third Party Controls
Acusera Third Party ControlsAcusera Third Party Controls
Acusera Third Party Controls
 
EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649
 
Acusera Third Party Quality Controls for Medical Laboratories
Acusera Third Party Quality Controls for Medical Laboratories Acusera Third Party Quality Controls for Medical Laboratories
Acusera Third Party Quality Controls for Medical Laboratories
 
The Importance of Third Party Controls
The Importance of Third Party ControlsThe Importance of Third Party Controls
The Importance of Third Party Controls
 
Acusera 24.7 QC Data Management
Acusera 24.7 QC Data ManagementAcusera 24.7 QC Data Management
Acusera 24.7 QC Data Management
 
Understanding statistics in laboratory quality control
Understanding statistics in laboratory quality controlUnderstanding statistics in laboratory quality control
Understanding statistics in laboratory quality control
 
Monitoring EQA / PT Performance
Monitoring EQA / PT PerformanceMonitoring EQA / PT Performance
Monitoring EQA / PT Performance
 
LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17
 
Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory Troubleshooting Poor EQA/QC Performance in the Laboratory
Troubleshooting Poor EQA/QC Performance in the Laboratory
 
Acusera 24.7 Interlaboratory Data Management
Acusera 24.7 Interlaboratory Data Management Acusera 24.7 Interlaboratory Data Management
Acusera 24.7 Interlaboratory Data Management
 
WESTGARD RULES
WESTGARD RULESWESTGARD RULES
WESTGARD RULES
 

Viewers also liked

Microsoft × Go
Microsoft × GoMicrosoft × Go
Microsoft × Go
Ryuji Iwata
 
Calcium & phosphate metabolism
Calcium & phosphate metabolismCalcium & phosphate metabolism
Calcium & phosphate metabolism
dr neetu singh
 
01 msu disorders of pancreas hajhamad m
01 msu disorders of pancreas hajhamad m01 msu disorders of pancreas hajhamad m
01 msu disorders of pancreas hajhamad m
Mohammed M. H. Hajhamad
 
MANAJEMEN PEMASARAN
MANAJEMEN PEMASARANMANAJEMEN PEMASARAN
MANAJEMEN PEMASARAN
riskarahma
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
Sam Malenab
 
Acute Complications of Diabetes Mellitus
Acute Complications of Diabetes MellitusAcute Complications of Diabetes Mellitus
Acute Complications of Diabetes Mellitus
Reshma Ann Mathew
 
Construcción de reticulas
Construcción de reticulasConstrucción de reticulas
Construcción de reticulas
ESPOL
 
Elementos basicos de comunicacion visual
Elementos basicos de comunicacion visualElementos basicos de comunicacion visual
Elementos basicos de comunicacion visual
Victoria Diaz
 
Training module III - Urinalysis
Training module III - UrinalysisTraining module III - Urinalysis
Training module III - Urinalysis
Jacquelyn Burns
 
Calcium and phosphorus metabolism /dental courses
Calcium and phosphorus metabolism /dental coursesCalcium and phosphorus metabolism /dental courses
Calcium and phosphorus metabolism /dental courses
Indian dental academy
 
Pancreatic disorder
Pancreatic disorderPancreatic disorder
Pancreatic disorder
specialclass
 
Liver function test
Liver function testLiver function test
Liver function test
dr anurag giri
 
Calcium metabolism
Calcium metabolismCalcium metabolism
Samsung SM R360 Tizen Smartwatch User Manual
Samsung SM R360 Tizen Smartwatch User Manual Samsung SM R360 Tizen Smartwatch User Manual
Samsung SM R360 Tizen Smartwatch User Manual
TizenExperts
 
Newborn Screening
Newborn ScreeningNewborn Screening
Newborn Screening
Rakshith AVB
 
Massive transfusion protocol
Massive transfusion protocolMassive transfusion protocol
Massive transfusion protocol
DR SHADAB KAMAL
 
Fundamentos13 neoclasicismo
Fundamentos13 neoclasicismo Fundamentos13 neoclasicismo
Fundamentos13 neoclasicismo
María José Gómez Redondo
 
Liver function test
Liver function testLiver function test
Liver function test
Gavin Yap
 
วิชาการศึกษา, ข้อสอบครูผู้ช่วย
วิชาการศึกษา, ข้อสอบครูผู้ช่วยวิชาการศึกษา, ข้อสอบครูผู้ช่วย
วิชาการศึกษา, ข้อสอบครูผู้ช่วย
ปกรณ์กฤช ออนไลน์
 
Massive Blood Transfusion
Massive Blood TransfusionMassive Blood Transfusion
Massive Blood Transfusion
Saeed Al-Shomimi
 

Viewers also liked (20)

Microsoft × Go
Microsoft × GoMicrosoft × Go
Microsoft × Go
 
Calcium & phosphate metabolism
Calcium & phosphate metabolismCalcium & phosphate metabolism
Calcium & phosphate metabolism
 
01 msu disorders of pancreas hajhamad m
01 msu disorders of pancreas hajhamad m01 msu disorders of pancreas hajhamad m
01 msu disorders of pancreas hajhamad m
 
MANAJEMEN PEMASARAN
MANAJEMEN PEMASARANMANAJEMEN PEMASARAN
MANAJEMEN PEMASARAN
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Acute Complications of Diabetes Mellitus
Acute Complications of Diabetes MellitusAcute Complications of Diabetes Mellitus
Acute Complications of Diabetes Mellitus
 
Construcción de reticulas
Construcción de reticulasConstrucción de reticulas
Construcción de reticulas
 
Elementos basicos de comunicacion visual
Elementos basicos de comunicacion visualElementos basicos de comunicacion visual
Elementos basicos de comunicacion visual
 
Training module III - Urinalysis
Training module III - UrinalysisTraining module III - Urinalysis
Training module III - Urinalysis
 
Calcium and phosphorus metabolism /dental courses
Calcium and phosphorus metabolism /dental coursesCalcium and phosphorus metabolism /dental courses
Calcium and phosphorus metabolism /dental courses
 
Pancreatic disorder
Pancreatic disorderPancreatic disorder
Pancreatic disorder
 
Liver function test
Liver function testLiver function test
Liver function test
 
Calcium metabolism
Calcium metabolismCalcium metabolism
Calcium metabolism
 
Samsung SM R360 Tizen Smartwatch User Manual
Samsung SM R360 Tizen Smartwatch User Manual Samsung SM R360 Tizen Smartwatch User Manual
Samsung SM R360 Tizen Smartwatch User Manual
 
Newborn Screening
Newborn ScreeningNewborn Screening
Newborn Screening
 
Massive transfusion protocol
Massive transfusion protocolMassive transfusion protocol
Massive transfusion protocol
 
Fundamentos13 neoclasicismo
Fundamentos13 neoclasicismo Fundamentos13 neoclasicismo
Fundamentos13 neoclasicismo
 
Liver function test
Liver function testLiver function test
Liver function test
 
วิชาการศึกษา, ข้อสอบครูผู้ช่วย
วิชาการศึกษา, ข้อสอบครูผู้ช่วยวิชาการศึกษา, ข้อสอบครูผู้ช่วย
วิชาการศึกษา, ข้อสอบครูผู้ช่วย
 
Massive Blood Transfusion
Massive Blood TransfusionMassive Blood Transfusion
Massive Blood Transfusion
 

Similar to FOCUS 2016 Poster: Specific Proteins

Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Waters Corporation
 
Validation of bevacizumab elisa ich q2 ver3,0 dt14.03
Validation of bevacizumab elisa   ich q2 ver3,0 dt14.03Validation of bevacizumab elisa   ich q2 ver3,0 dt14.03
Validation of bevacizumab elisa ich q2 ver3,0 dt14.03
krishgen
 
zidovudine hplc method
zidovudine hplc method zidovudine hplc method
zidovudine hplc method
Aparna Rajeevi
 
Chromatography: Meeting the Challenges of EU regulations with up-to-date Conf...
Chromatography: Meeting the Challenges of EU regulations with up-to-date Conf...Chromatography: Meeting the Challenges of EU regulations with up-to-date Conf...
Chromatography: Meeting the Challenges of EU regulations with up-to-date Conf...
Chromatography & Mass Spectrometry Solutions
 
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
SGS
 
Session 5d TISTR CRM Production
Session 5d TISTR CRM ProductionSession 5d TISTR CRM Production
Session 5d TISTR CRM Production
Paramee Kumkrong Mester
 
Nitrogen_Protein Determination of Spirulina Algae.pdf
Nitrogen_Protein Determination of Spirulina Algae.pdfNitrogen_Protein Determination of Spirulina Algae.pdf
Nitrogen_Protein Determination of Spirulina Algae.pdf
NguyenMinhChau22
 
RX-monaco.pdf
RX-monaco.pdfRX-monaco.pdf
RX-monaco.pdf
Marketingtechnobmed
 
Quality assurance in haematology
Quality assurance in haematologyQuality assurance in haematology
Quality assurance in haematology
Ishwar Bihana
 
Determination of Elemental Impurities – Challenges of a Screening Method
Determination of Elemental Impurities – Challenges of a Screening MethodDetermination of Elemental Impurities – Challenges of a Screening Method
Determination of Elemental Impurities – Challenges of a Screening Method
SGS
 
BR-70346-Research-Production-Biofuel-BR70346-EN
BR-70346-Research-Production-Biofuel-BR70346-ENBR-70346-Research-Production-Biofuel-BR70346-EN
BR-70346-Research-Production-Biofuel-BR70346-EN
dmend129
 
Qc
QcQc
Method Development and Method Validation for the estimation of Valganciclovir...
Method Development and Method Validation for the estimation of Valganciclovir...Method Development and Method Validation for the estimation of Valganciclovir...
Method Development and Method Validation for the estimation of Valganciclovir...
google
 
Determination of 3-chloropropanediol in soy sauce samples by liquid phase ext...
Determination of 3-chloropropanediol in soy sauce samples by liquid phase ext...Determination of 3-chloropropanediol in soy sauce samples by liquid phase ext...
Determination of 3-chloropropanediol in soy sauce samples by liquid phase ext...
International Multispeciality Journal of Health
 
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MSQuantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
Covance
 
Improved Analytical Methods for Carbohydrate R&D
Improved Analytical Methods for Carbohydrate R&DImproved Analytical Methods for Carbohydrate R&D
Improved Analytical Methods for Carbohydrate R&D
Richard Sevcik
 
EARS-Net EQA 2014. Derek Brown (UK)
EARS-Net EQA 2014. Derek Brown (UK)EARS-Net EQA 2014. Derek Brown (UK)
Improvement of bacterial estimation in urinalysis by iQ®200 ELITE®: capture i...
Improvement of bacterial estimation in urinalysis by iQ®200 ELITE®: capture i...Improvement of bacterial estimation in urinalysis by iQ®200 ELITE®: capture i...
Improvement of bacterial estimation in urinalysis by iQ®200 ELITE®: capture i...
kridsada31
 
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
CrimsonpublishersNTNF
 
QDx sample report_dual language- General Screening
QDx sample report_dual language- General ScreeningQDx sample report_dual language- General Screening
QDx sample report_dual language- General Screening
Ruby Amaran
 

Similar to FOCUS 2016 Poster: Specific Proteins (20)

Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
 
Validation of bevacizumab elisa ich q2 ver3,0 dt14.03
Validation of bevacizumab elisa   ich q2 ver3,0 dt14.03Validation of bevacizumab elisa   ich q2 ver3,0 dt14.03
Validation of bevacizumab elisa ich q2 ver3,0 dt14.03
 
zidovudine hplc method
zidovudine hplc method zidovudine hplc method
zidovudine hplc method
 
Chromatography: Meeting the Challenges of EU regulations with up-to-date Conf...
Chromatography: Meeting the Challenges of EU regulations with up-to-date Conf...Chromatography: Meeting the Challenges of EU regulations with up-to-date Conf...
Chromatography: Meeting the Challenges of EU regulations with up-to-date Conf...
 
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
 
Session 5d TISTR CRM Production
Session 5d TISTR CRM ProductionSession 5d TISTR CRM Production
Session 5d TISTR CRM Production
 
Nitrogen_Protein Determination of Spirulina Algae.pdf
Nitrogen_Protein Determination of Spirulina Algae.pdfNitrogen_Protein Determination of Spirulina Algae.pdf
Nitrogen_Protein Determination of Spirulina Algae.pdf
 
RX-monaco.pdf
RX-monaco.pdfRX-monaco.pdf
RX-monaco.pdf
 
Quality assurance in haematology
Quality assurance in haematologyQuality assurance in haematology
Quality assurance in haematology
 
Determination of Elemental Impurities – Challenges of a Screening Method
Determination of Elemental Impurities – Challenges of a Screening MethodDetermination of Elemental Impurities – Challenges of a Screening Method
Determination of Elemental Impurities – Challenges of a Screening Method
 
BR-70346-Research-Production-Biofuel-BR70346-EN
BR-70346-Research-Production-Biofuel-BR70346-ENBR-70346-Research-Production-Biofuel-BR70346-EN
BR-70346-Research-Production-Biofuel-BR70346-EN
 
Qc
QcQc
Qc
 
Method Development and Method Validation for the estimation of Valganciclovir...
Method Development and Method Validation for the estimation of Valganciclovir...Method Development and Method Validation for the estimation of Valganciclovir...
Method Development and Method Validation for the estimation of Valganciclovir...
 
Determination of 3-chloropropanediol in soy sauce samples by liquid phase ext...
Determination of 3-chloropropanediol in soy sauce samples by liquid phase ext...Determination of 3-chloropropanediol in soy sauce samples by liquid phase ext...
Determination of 3-chloropropanediol in soy sauce samples by liquid phase ext...
 
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MSQuantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MS
 
Improved Analytical Methods for Carbohydrate R&D
Improved Analytical Methods for Carbohydrate R&DImproved Analytical Methods for Carbohydrate R&D
Improved Analytical Methods for Carbohydrate R&D
 
EARS-Net EQA 2014. Derek Brown (UK)
EARS-Net EQA 2014. Derek Brown (UK)EARS-Net EQA 2014. Derek Brown (UK)
EARS-Net EQA 2014. Derek Brown (UK)
 
Improvement of bacterial estimation in urinalysis by iQ®200 ELITE®: capture i...
Improvement of bacterial estimation in urinalysis by iQ®200 ELITE®: capture i...Improvement of bacterial estimation in urinalysis by iQ®200 ELITE®: capture i...
Improvement of bacterial estimation in urinalysis by iQ®200 ELITE®: capture i...
 
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
 
QDx sample report_dual language- General Screening
QDx sample report_dual language- General ScreeningQDx sample report_dual language- General Screening
QDx sample report_dual language- General Screening
 

More from Randox

Randox QC Pancake IFU
Randox QC Pancake IFURandox QC Pancake IFU
Randox QC Pancake IFU
Randox
 
RIQAS Calendar 2017
RIQAS Calendar 2017RIQAS Calendar 2017
RIQAS Calendar 2017
Randox
 
Step by Step Guide to Preparing QC
Step by Step Guide to Preparing QCStep by Step Guide to Preparing QC
Step by Step Guide to Preparing QC
Randox
 
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
Randox
 
White Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care TestingWhite Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care Testing
Randox
 
Uso de Multireglas CC
Uso de Multireglas CCUso de Multireglas CC
Uso de Multireglas CC
Randox
 
Acusera Verify Presentation
Acusera Verify PresentationAcusera Verify Presentation
Acusera Verify Presentation
Randox
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Randox
 
Monitoring EQA/PT Performance (Polish)
Monitoring EQA/PT Performance (Polish)Monitoring EQA/PT Performance (Polish)
Monitoring EQA/PT Performance (Polish)
Randox
 
ACB Focus 2015 Poster
ACB Focus 2015 PosterACB Focus 2015 Poster
ACB Focus 2015 Poster
Randox
 

More from Randox (10)

Randox QC Pancake IFU
Randox QC Pancake IFURandox QC Pancake IFU
Randox QC Pancake IFU
 
RIQAS Calendar 2017
RIQAS Calendar 2017RIQAS Calendar 2017
RIQAS Calendar 2017
 
Step by Step Guide to Preparing QC
Step by Step Guide to Preparing QCStep by Step Guide to Preparing QC
Step by Step Guide to Preparing QC
 
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
 
White Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care TestingWhite Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care Testing
 
Uso de Multireglas CC
Uso de Multireglas CCUso de Multireglas CC
Uso de Multireglas CC
 
Acusera Verify Presentation
Acusera Verify PresentationAcusera Verify Presentation
Acusera Verify Presentation
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?
 
Monitoring EQA/PT Performance (Polish)
Monitoring EQA/PT Performance (Polish)Monitoring EQA/PT Performance (Polish)
Monitoring EQA/PT Performance (Polish)
 
ACB Focus 2015 Poster
ACB Focus 2015 PosterACB Focus 2015 Poster
ACB Focus 2015 Poster
 

Recently uploaded

Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
Bath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptxBath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptx
MianProductions
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
Dr Rachana Gujar
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
Conference Panel
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
aditigupta1117
 
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfComprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Dr Rachana Gujar
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
rightmanforbloodline
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
priyabhojwani1200
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
SHAMIN EABENSON
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
Vishal kr Thakur
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
rightmanforbloodline
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURYDR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
SHAMIN EABENSON
 

Recently uploaded (20)

Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
Bath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptxBath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptx
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
 
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfComprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURYDR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
 

FOCUS 2016 Poster: Specific Proteins

  • 1. W QUALITY CONTROL Human ready-to-use stable liquid multi-analyte control for specific proteins including antibody isotypes and complement components Spon-Smith C., Shanks A., Rodríguez M.L., Campbell J., FitzGerald S.P | Randox Laboratories Ltd - Diamond Road, Crumlin, County Antrim, N. Ireland, BT29 4QY, United Kingdom. Introduction The performance and interpretation of tests for the diagnosis and management of a variety of immune-mediated diseases requires the maintenance of high-quality output. Quality control material is required to monitor the accuracy and precision of the tests,this will lead to improved result quality. The use of liquid stable multi-analyte control material consolidates the test menu, reduces the risk of errors associated with reconstitution and decreases the operator training requirements. A human liquid ready-to-use,stable multi-analyte control containing antibody isotypes, complement components and other specific proteins is reported. Methodology •Three levels of human liquid control material containing 27 analytes were prepared. • Open vial stability was determined as the percentage recovery of each level of analyte opened and stored at +2°C to +8°C over a period of 30 days related to day 0 at +2°C to +8°C. • Shelf life was assessed as the percentage recovery of each level of analyte stored at +2°C to +8°C compared to the same material stored at -70°C over a 48 month period. Measurements were made on various automated systems. Conclusion Thehumanliquidmulti-analytecontrolmaterialforspecificproteinscontained27parameters at three levels covering clinically relevant ranges.This control material presented an open vial stability of 30 days and data supporting at least a 2 year shelf life.This control is of value as a convenient, ready-to-use material for clinical applications. Randox Laboratories Ltd, 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom +44 (0) 28 9442 2413 +44 (0) 28 9445 2912 marketing@randox.com randoxqc.comQUALITY CONTROL Analyte Unit Level 1 Level 2 Level 3 Method Target Range Target Range Target Range CRP mg/L 27.5 22.0-33.0 54.6 43.7-65.5 81.8 65.4-98.2 Turbidimetric mg/L 25.3 20.2-30.4 52.9 42.3-63.5 79.1 63.3-94.9 Nephelometric mg/L 36.2 29.0-43.4 58.6 47-70.3 64.5 51.6-77.4 Vitros Complement C3 g/L 0.72 0.57-0.86 1.45 1.16-1.74 2.17 1.74-2.60 Turbidimetric mg/dL 72.0 57.6-86.4 145 116-174 217 174-260 g/L 0.727 0.58-0.87 1.49 1.19-1.79 2.27 1.82-2.72 Nephelometric mg/dL 72.7 58.2-87.2 149 119-179 227 182-272 g/L 0.714 0.57-0.85 1.40 1.12-1.68 2.15 1.72-2.58 Vitros mg/dL 71.4 57.1-85.7 140 112-168 215 172-258 Complement C4 g/L 0.175 0.14-0.21 0.35 0.28-0.42 0.53 0.42-0.63 Turbidimetric mg/dL 17.5 14.0-21.0 35 28-42 53 42.4-63.6 g/L 0.196 0.15-0.23 0.399 0.31-0.47 0.60 0.48-0.72 Nephelometric mg/dL 19.6 15.7-23.5 39.9 31.9-47.9 60.4 48.3-72.5 g/L 0.181 0.14-0.22 0.356 0.28-0.42 0.53 0.42-0.63 Vitros mg/dL 18.1 14.5-21.7 35.6 28.5-42.7 53 42.4-63.6 Free Kappa Light Chains mg/L 17.9 14.3-21.5 29.9 23.9-35.9 34 25.5-42.5 Turbidimetric mg/L 21.7 17.4-26.0 34.2 27.4-41.0 40.2 30.2-50.3 Nephelometric Free Lambda Light Chains mg/L 16.9 13.5-20.3 29.4 23.5-35.3 40.3 30.2-50.4 Turbidimetric mg/L 18.4 14.7-22.1 33.3 26.6-40 46.3 34.7-57.9 Nephelometric IgA g/L 1.22 0.91-1.53 2.42 1.82-3.03 3.65 2.74-4.56 Turbidimetric mg/dL 122 91.5-153 242 182-302 365 274-456 g/L 1.29 0.96-1.61 2.64 1.98-3.30 4.04 3.03-5.05 Nephelometric mg/dL 129 96.8-161 264 198-330 404 303-505 g/L 1.18 0.88-1.48 2.48 1.86-3.10 3.46 2.60-4.33 Vitros mg/dL 118 88.5-148 248 186-310 346 260-432 IgE KIU/L = IU/mL 89.3 71.4-107 175 140-210 262 210-314 Turbidimetric KIU/L = IU/mL 100 80-120 198 158-238 310 248-372 Nephelometric KIU/L = IU/mL 103 82.4-124 200 160-240 299 239-359 Chemiluminescence KIU/L = IU/mL 100 80-120 211 169-253 299 239-359 Enzyme Immunoassay KIU/L = IU/mL 105 84-126 210 168-252 315 252-378 Fluorimetric IgG g/L 7.0 5.74-8.26 14 11.5-16.5 21 17.2-24.8 Turbidimetric mg/dL 700 574-826 1400 1150-1650 2100 1720-2480 g/L 7.34 6.02-8.66 14.5 11.9-17.1 21.6 17.7-25.5 Nephelometric mg/dL 734 602-866 1450 1190-1710 2160 1770-2550 g/L 7.14 5.85-8.43 14 11.5-16.5 19.6 16.1-23.1 Vitros mg/dL 714 585-843 1400 1150-1650 1960 1610-2310 IgM g/L 0.94 0.75-1.13 1.87 1.50-2.24 2.83 2.26-3.40 Turbidimetric mg/dL 94 75.2-113 187 150-224 283 226-340 g/L 0.99 0.79-1.19 1.96 1.57-2.35 2.95 2.36-3.54 Nephelometric mg/dL 99 79.2-119 196 157-235 295 236-354 g/L 0.917 0.73-1.10 1.97 1.58-2.36 2.73 2.18-3.28 Vitros mg/dL 91.7 73.4-110 197 158-236 273 218-328 Kappa Light Chain g/L 1.83 1.46-2.20 3.71 2.97-4.45 5.55 4.16-6.94 Turbidimetric mg/dL 183 146-220 371 297-445 555 416-694 g/L 1.87 1.50-2.24 3.57 2.86-4.28 5.40 4.05-6.75 Nephelometric mg/dL 187 150-224 357 286-428 540 405-675 Lambda Light Chain g/L 0.924 0.73-1.11 1.87 1.50-2.24 2.89 2.17-3.61 Turbidimetric mg/dL 92.4 73.9-111 187 150-224 289 217-361 g/L 0.962 0.77-1.15 1.88 1.50-2.26 2.87 2.15-3.59 Nephelometric mg/dL 96.2 77-115 188 150-226 287 215-359 Results - Examples of typical ranges Open vial stability Temperature Time period Recovery (%) for different concentration levels for all the analytes +2ºC to +8ºC 30 days (from day 0) 90-110 Shelf life stability Temperature Time period Recovery (%) for different concentration levels for all the analytes +2ºC to +8ºC 48 months 90-110 Stability AFP Complement C3 Kappa Light Chain (free) Albumin Complement C4 Lambda Light Chain α-I-Antitrypsin CRP Lambda Light Chain (free) α-I-Acid Glycoprotein Haptoglobin Prealbumin (Transthyretin) α-2-Macroglobulin IgA Serum Ferritin ASO IgE RF Anti-thrombin III IgG RBP β-2-Microglobulin IgM Total Protein Ceruloplasmin Kappa Light Chain Transferrin Analytes